Anastomosis Devices Market by Product, Application, End User

KEY MARKET STATISTICS
Base Year [2023]	USD 2.82 billion
Estimated Year [2024]	USD 3.04 billion
Forecast Year [2030]	USD 4.82 billion
CAGR (%)	7.96%

The FPNV Positioning Matrix is pivotal in evaluating the Anastomosis Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anastomosis Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anastomosis Devices Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Cryolife, Inc., Getinge AB, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic Plc, MedVision Group, Meril Life Sciences Pvt. Ltd., Peters Surgical SASU, Purple Surgical, Seger Surgical Solutions Ltd, Synovis Micro Companies Alliance, Inc., and VITALITEC International Medical Technology GmbH.

Market Segmentation & Coverage

This research report categorizes the Anastomosis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Surgical Sealants & Adhesives
  - Natural or Biological Surgical Sealants & Adhesives
    - Albumin-Based Sealants & Adhesives
    - Collagen-Based Sealants and Adhesives
    - Fibrin-Based Sealants & Adhesives
  - Synthetic and Semisynthetic Sealants & Adhesive
    - Cyanoacrylate-Based Sealants & Adhesives
    - Peg Hydrogel-Based Sealants & Adhesives
    - Urethane-Based Sealants & Adhesives
- Surgical Staplers
  - Manual Surgical Staplers
  - Powered Surgical Staplers
- Surgical Sutures
  - Absorbable Sutures
    - Natural Sutures
    - Synthetic Sutures
    - Poliglecaprone 25 Sutures
    - Polydioxanone Sutures
    - Polyglactin 910 Sutures
    - Polyglycolic Acid Sutures
  - Automated Suturing Devices
    - Disposable Automated Suturing Devices
    - Reusable Automated Suturing Devices
  - Non-Absorbable Sutures
    - Nylon Sutures
    - Polypropylene Sutures
    - Stainless Steel Sutures
Application
- Cardiovascular & Thoracic Surgeries
- Gastrointestinal Surgeries
End User
- Ambulatory Surgery Centers & Clinics
- Hospitals
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anastomosis Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anastomosis Devices Market?

3. What are the technology trends and regulatory frameworks in the Anastomosis Devices Market?

4. What is the market share of the leading vendors in the Anastomosis Devices Market?

5. Which modes and strategic moves are suitable for entering the Anastomosis Devices Market?

Product Code: MRR-431F213C91E5

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Anastomosis Devices Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of off-pump, endoscopic, and minimally invasive surgeries
  - 5.1.1.2. Proliferation of cardiovascular and gastrointestinal diseases
  - 5.1.1.3. Increasing incidence of target diseases and the growing number of surgical procedures
- 5.1.2. Restraints
  - 5.1.2.1. High cost of devices and extensive clinical data requirements for product launch
- 5.1.3. Opportunities
  - 5.1.3.1. Refinement of automated distal anastomotic devices
  - 5.1.3.2. Increasing R&D activities and soaring healthcare expenditure
- 5.1.4. Challenges
  - 5.1.4.1. Frequent product recalls and dearth of trained professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Anastomosis Devices Market, by Product

6.1. Introduction
6.2. Surgical Sealants & Adhesives
- 6.3.1. Natural or Biological Surgical Sealants & Adhesives
  - 6.3.2.1. Albumin-Based Sealants & Adhesives
  - 6.3.2.2. Collagen-Based Sealants and Adhesives
  - 6.3.2.3. Fibrin-Based Sealants & Adhesives
- 6.3.2. Synthetic and Semisynthetic Sealants & Adhesive
  - 6.3.3.1. Cyanoacrylate-Based Sealants & Adhesives
  - 6.3.3.2. Peg Hydrogel-Based Sealants & Adhesives
  - 6.3.3.3. Urethane-Based Sealants & Adhesives
6.3. Surgical Staplers
- 6.4.1. Manual Surgical Staplers
- 6.4.2. Powered Surgical Staplers
6.4. Surgical Sutures
- 6.5.1. Absorbable Sutures
  - 6.5.2.1. Natural Sutures
  - 6.5.2.2. Synthetic Sutures
  - 6.5.2.3.1. Poliglecaprone 25 Sutures
  - 6.5.2.3.2. Polydioxanone Sutures
  - 6.5.2.3.3. Polyglactin 910 Sutures
  - 6.5.2.3.4. Polyglycolic Acid Sutures
- 6.5.2. Automated Suturing Devices
  - 6.5.3.1. Disposable Automated Suturing Devices
  - 6.5.3.2. Reusable Automated Suturing Devices
- 6.5.3. Non-Absorbable Sutures
  - 6.5.4.1. Nylon Sutures
  - 6.5.4.2. Polypropylene Sutures
  - 6.5.4.3. Stainless Steel Sutures

7. Anastomosis Devices Market, by Application

7.1. Introduction
7.2. Cardiovascular & Thoracic Surgeries
7.3. Gastrointestinal Surgeries

8. Anastomosis Devices Market, by End User

8.1. Introduction
8.2. Ambulatory Surgery Centers & Clinics
8.3. Hospitals

9. Americas Anastomosis Devices Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Anastomosis Devices Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Anastomosis Devices Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. B. Braun Melsungen AG
- 13.1.2. Becton, Dickinson and Company
- 13.1.3. Cryolife, Inc.
- 13.1.4. Getinge AB
- 13.1.5. Intuitive Surgical, Inc.
- 13.1.6. Johnson & Johnson Services, Inc.
- 13.1.7. LivaNova PLC
- 13.1.8. Medtronic Plc
- 13.1.9. MedVision Group
- 13.1.10. Meril Life Sciences Pvt. Ltd.
- 13.1.11. Peters Surgical SASU
- 13.1.12. Purple Surgical
- 13.1.13. Seger Surgical Solutions Ltd
- 13.1.14. Synovis Micro Companies Alliance, Inc.
- 13.1.15. VITALITEC International Medical Technology GmbH
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing